reviewed april 2026|next review october 2026|88 physicians psi has verified|316 published studies
HCG (Human Chorionic Gonadotropin)
Human chorionic gonadotropin (hCG) is a glycoprotein hormone FDA-approved for fertility treatment in multiple formulations (Pregnyl, Ovidrel, Novarel) and widely used in men's health to maintain testicular function during testosterone replacement therapy.
Evidence landscape: 316 published studies
316 published items. 48 human studies and 134 animal studies. One of the most studied hormonal peptides with decades of clinical use across fertility and men's health.
- 48 Human
- 134 Animal
- 18 Reviews
- 116 Other research
FDA-approved prescription medicine in multiple formulations for ovulation induction and treatment of hypogonadotropic hypogonadism.
Decades of clinical use in reproductive medicine. Widely practiced TRT adjunct use based on mechanistic evidence and clinical experience rather than large Phase III trials.
One of the most clinically validated hormonal peptides. The hCG diet is a thoroughly debunked weight loss claim; the FDA has issued explicit warnings against hCG weight loss products.
PSI Assessment
One of the most versatile hormonal peptides in clinical medicine serves two completely different patient populations. In fertility medicine, human chorionic gonadotropin triggers ovulation and is FDA-approved for assisted reproduction. In men's health, it mimics luteinizing hormone to maintain testicular function and sperm production during testosterone replacement therapy. It is also the subject of one of the most thoroughly debunked weight loss claims in peptide medicine: the hCG diet, which the FDA has explicitly warned against.
FDA-approved for fertility with decades of clinical use. The hCG diet is debunked; the FDA has issued explicit warnings against hCG weight loss products.
The mechanism is LH receptor agonism. hCG binds the same receptor as luteinizing hormone on Leydig cells in the testes (stimulating testosterone synthesis) and on ovarian granulosa cells (triggering final oocyte maturation and ovulation). In men on TRT, exogenous testosterone suppresses pituitary LH production, causing testicular atrophy and infertility. hCG fills in for the missing LH signal, keeping the testes active. The weight loss mechanism claimed by hCG diet promoters does not exist: controlled studies show no difference between hCG and placebo when caloric intake is equivalent.
What the evidence supports
FDA-approved for fertility treatment with decades of clinical data across multiple formulations. Reliably stimulates testosterone production via LH receptor agonism. Preserves spermatogenesis during TRT, widely practiced in men's health clinics. The mechanism is thoroughly characterized. The hCG diet is debunked: controlled studies show no difference between hCG and placebo when caloric intake is equivalent, and the FDA has issued explicit warnings.
What is not yet established
Optimal dosing protocols for TRT-adjacent use, based on clinical practice rather than large randomized controlled trials. Whether hCG is superior to alternatives like gonadorelin or enclomiphene for men's health applications. Long-term outcomes of chronic hCG use in men beyond fertility preservation.
Research Evidence
The findings below cover the established fertility and men's health applications and the debunked weight loss claims.
Evidence by condition
Evidence dimensions across hCG indications. Fertility treatment has the deepest evidence with FDA approval. TRT adjunct use is widely practiced with strong mechanistic support. The weight loss application is debunked.
| Condition | Mechanism | Animal evidence | Human evidence | Replication |
|---|---|---|---|---|
| Fertility Treatment | ||||
| TRT Adjunct | ||||
| Hypogonadism | ||||
| Weight Loss |
hCG is FDA-approved as an ovulation trigger in assisted reproduction, with decades of clinical use across IVF and fertility treatment protocols. Multiple formulations (urinary-derived Pregnyl, recombinant Ovidrel) are available.
Administration timing is precisely coordinated with follicular development monitoring. Risk of ovarian hyperstimulation syndrome (OHSS) requires careful dose adjustment. This is one of the most established applications of any hormonal peptide.
hCG preserves spermatogenesis and testicular volume during TRT by directly stimulating Leydig cells via LH receptor agonism. Typical doses of 500-1500 IU two to three times per week maintain intratesticular testosterone production.
Widely practiced in men's health clinics but based on clinical experience and mechanistic evidence rather than large randomized controlled trials. Can increase estrogen levels through aromatization of the stimulated testosterone, sometimes requiring management.
The hCG diet is debunked. A meta-analysis and multiple controlled studies show no difference in weight loss between hCG and placebo when caloric intake is equivalent. Any weight loss on the hCG diet is attributable to the accompanying 500-calorie diet, not hCG. The FDA has issued warnings against homeopathic hCG weight loss products.
This debunked claim persists in consumer markets despite FDA enforcement action. The distinction between the validated medical uses and the fraudulent weight loss claims is essential context for anyone researching this peptide.
48 Human|134 Animal|18 Reviews
View all 316 indexed studiesHow HCG (Human Chorionic Gonadotropin) Works
Human chorionic gonadotropin (hCG) is a glycoprotein hormone consisting of alpha and beta subunits. It binds the LH receptor (also called the LH/hCG receptor), stimulating testosterone synthesis in Leydig cells and triggering ovulation in ovarian follicles. Recombinant and urinary-derived formulations are FDA-approved.
hCG looks like LH to your testes. When you take TRT, your brain stops making LH because it detects enough testosterone. Without LH, the testes shrink and stop making sperm. hCG fills in for the missing LH, keeping the testes active even while on TRT.
For a more detailed view of the biology, here is what researchers have observed at the molecular level.
hCG binds the LH/CG receptor on Leydig cells, stimulating testosterone synthesis via cAMP/PKA pathway. It also maintains Sertoli cell function and spermatogenesis. In women, hCG triggers ovulation and supports the corpus luteum during early pregnancy.
What is HCG (Human Chorionic Gonadotropin) being studied for?
Researchers are studying HCG (Human Chorionic Gonadotropin) across several health conditions. Each condition below is labeled with the strength of evidence that exists for that specific use, not for HCG (Human Chorionic Gonadotropin) overall. This means a compound can have human studies for one condition but only animal data for another.
Fertility Treatment
·FDA ApprovedFDA-approved ovulation trigger for IVF and assisted reproductive technology. Decades of clinical use in fertility medicine across multiple formulations.
Limitations: Risk of ovarian hyperstimulation syndrome (OHSS) requires careful monitoring and dose adjustment. Timing must be precisely coordinated with follicular development.
TRT Adjunct
·Human TrialsPreserves spermatogenesis and testicular volume during testosterone replacement therapy by maintaining intratesticular testosterone production via LH receptor stimulation.
Limitations: Optimal dosing protocols based on clinical practice rather than large randomized controlled trials. Can increase estrogen levels requiring monitoring. Comparative data against gonadorelin or enclomiphene is limited.
Hypogonadism
·Human TrialsStimulates the body's own testosterone production in secondary hypogonadism by directly activating Leydig cells. Used as monotherapy or adjunct in men with intact testicular function.
Limitations: Less effective in primary hypogonadism where Leydig cell function is impaired. Head-to-head comparison data with TRT for clinical outcomes is limited.
Weight Loss
·PreclinicalDebunked. Controlled studies show no difference between hCG and placebo for weight loss when caloric intake is equivalent. The FDA has issued warnings against homeopathic hCG weight loss products.
Limitations: Any weight loss on the hCG diet is attributable to the 500-calorie diet, not hCG. Homeopathic hCG products are fraudulent.
Safety and Regulatory Status
FDA Status: FDA-approved in multiple formulations: Pregnyl (urinary-derived), Ovidrel (recombinant), Novarel for ovulation induction and hypogonadism treatment.
Prescription status: Prescription-only in the United States for FDA-approved indications. hCG diet products are not FDA-approved and the FDA has issued warnings against them.
Class context: Glycoprotein hormone acting via LH receptor agonism. Gonadorelin provides an alternative approach to maintaining testicular function by stimulating the body's own LH production.
Side effects include injection site pain, headache, and mood changes. In men, hCG can increase estrogen levels through aromatization of the testosterone it stimulates, which may require management. OHSS is the primary risk in fertility applications and requires monitoring.
Questions and Comparisons
Questions the evidence raises for a HCG (Human Chorionic Gonadotropin) discussion.
Comparison and Related Research
hCG is most often compared with gonadorelin (which stimulates LH production rather than mimicking LH directly) and enclomiphene (which blocks estrogen feedback to increase LH). The comparisons below outline the mechanistic and evidence differences.
Related compounds
Frequently Asked Questions
References
Each citation links to the original study on PubMed, the U.S. National Library of Medicine database.
- 1.Demonstrated that low-dose hCG can maintain testosterone production inside the testes even when exogenous testosterone has shut down the body's natural signaling. This is the mechanistic basis for using hCG alongside testosterone replacement therapy to preserve fertility.Coviello AD et al., 2005 in J Clin Endocrinol Metab. View on PubMed
- 2.Meta-analysis examining hCG for weight loss as part of the Simeons diet protocol. After reviewing all available controlled studies, the authors concluded there was no scientific evidence that hCG is effective as a weight loss treatment beyond what the calorie-restricted diet alone produces.Lijesen GK et al., 1995 in Br J Clin Pharmacol. View on PubMed
- 3.Randomized study comparing hCG to clomiphene citrate for restoring testosterone levels in men with hypogonadism. Both treatments effectively raised testosterone, providing clinical evidence for hCG as a standalone option in men with low testosterone who want to preserve fertility.Habous M et al., 2018 in BJU Int. View on PubMed
- 4.Review of clinical indications for hCG in managing male infertility associated with low testosterone. Covered the evidence for hCG as both a standalone treatment and as an adjunct to testosterone therapy to maintain sperm production.Lee JA et al., 2018 in Transl Androl Urol. View on PubMed
Medical Disclaimer
This content is for educational and informational purposes only and does not constitute medical advice. The information presented reflects published research as indexed by PSI and should not be used to make treatment decisions. Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment.